SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-18-003806
Filing Date
2018-03-23
Accepted
2018-03-23 16:06:31
Documents
48
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1313095
2 ex31.htm EX-31 11235
3 ex32.htm EX-32 6263
  Complete submission text file 0001493152-18-003806.txt   3821878

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE lixt-20171231.xml EX-101.INS 499581
5 XBRL SCHEMA FILE lixt-20171231.xsd EX-101.SCH 41328
6 XBRL CALCULATION FILE lixt-20171231_cal.xml EX-101.CAL 34775
7 XBRL DEFINITION FILE lixt-20171231_def.xml EX-101.DEF 151198
8 XBRL LABEL FILE lixt-20171231_lab.xml EX-101.LAB 273431
9 XBRL PRESENTATION FILE lixt-20171231_pre.xml EX-101.PRE 205244
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE
Type: 10-K | Act: 34 | File No.: 000-51476 | Film No.: 18710154
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences